Respiratory syncytial virus -viral biology and the host response, J Infect, vol.45, pp.18-24, 2002. ,
Viral and host factors in human respiratory syncytial virus pathogenesis, J Virol, vol.82, pp.2040-55, 2008. ,
Respiratory syncytial virus infection: immune response, immunopathogenesis, and treatment, Clin Microbiol Rev, vol.12, pp.298-309, 1999. ,
Respiratory syncytial virus infection suppresses lung CD8 + T-cell effector activity and peripheral CD8 ,
, + T-cell memory in the respiratory tract, Nat Med, vol.8, pp.54-60, 2002.
Respiratory syncytial virus and T cells: interplay between the virus and the host adaptive immune system, Proc Am Thorac Soc, vol.2, pp.141-147, 2005. ,
Respiratory syncytial virus impairs T cell activation by preventing synapse assembly with dendritic cells, Proc Natl Acad Sci U S A, vol.105, pp.14999-5004, 2008. ,
Respiratory syncytial virus infection of monocyte-derived dendritic cells decreases their capacity to activate CD4 T cells, J Immunol, vol.175, pp.5904-5915, 2005. ,
Recovery from infants with respiratory illness of a virus related to chimpanzee coryza agent (CCA): isolation, properties and characterization, Am J Hyg, vol.66, pp.281-90, 1957. ,
Deletion of a prophage-like element causes attenuation of Salmonella enterica serovar Enteritidis and promotes protective immunity, Vaccine, vol.28, pp.5458-66, 2010. ,
An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine, Am J Epidemiol, vol.89, pp.405-426, 1969. ,
Respiratory syncytial virus disease in infants despite prior aministration of antigenic inactivated vaccine, Am J Epidemiol, vol.89, pp.422-456, 1969. ,
Excision of an unstable pathogenicity island in Salmonella enterica serovar Enteritidis is induced during infection of phagocytic cells, PLoS ONE, vol.6, p.26031, 2011. ,
Spontaneous excision of the Salmonella enterica serovar Enteritidis-specific defective prophage-like element phiSE14, J Bacteriol, vol.192, pp.2246-54, 2010. ,
Prevention of respiratory syncytial virus infections: indications for the use of palivizumab and update on the use of RSV-IGIV, Pediatrics, vol.102, pp.1211-1217, 1998. ,
Dvelopment of a humanized monoclonal antibody (MEDI-493) with potent in vitro and in vivo activity against respiratory syncytial virus, J Infect Dis, vol.176, pp.1215-1239, 1997. ,
a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants, Pediatrics, vol.102, issue.3, pp.531-538, 1998. ,
Anti-respiratory syncytial virus (RSV) neutralizing antibody decreases lung inflammation, airway obstruction, and airway hyperresponsiveness in a murine RSV model, Antimicrob Agents Chemother, vol.48, pp.1811-1833, 2004. ,
Comparative effects of two neutralizing anti-respiratory syncytial virus (RSV) monoclonal antibodies in the RSV murine model: time versus potency, Antimicrob Agents Chemother, vol.49, pp.4700-4707, 2005. ,
Palivizumab for preterm infants. Is it worth it?, Arch Dis Child Fetal Neonatal Ed, vol.90, pp.286-295, 2005. ,
Passive immunisation of preterm infants with palivizumab against RSV infection, J Infect, vol.52, pp.2-8, 2006. ,
Fcc receptors in respiratory syncytial virus infections: implications for innate immunity, Rev Med Virol, vol.24, pp.55-70, 2014. ,
, Serum antibodies critically affect virus-specific CD4
,
, + T cell balance during respiratory syncytial virus infections, J Immunol, vol.185, pp.6489-98, 2010.
Intranasal administration of antibody-bound respiratory syncytial virus particles efficiently primes virus-specific immune responses in mice, J Virol, vol.87, pp.7550-7557, 2013. ,
Immune complexinduced enhancement of bacterial antigen presentation requires Fcc receptor III expression on dendritic cells, Proc Natl Acad Sci U S A, vol.104, pp.13402-13409, 2007. ,
Modulation of T cell immunity by TCR/pMHC dwell time and activating/ inhibitory receptor pairs on the antigen-presenting cell, Curr Pharm Des, vol.9, pp.233-277, 2003. ,
Salmonella escape from antigen presentation can be overcome by targeting bacteria to Fcc receptors on dendritic cells, J Immunol, vol.173, pp.4058-65, 2004. ,
Fc receptor-mediated phagocytosis makes a significant contribution to clearance of influenza virus infections, J Immunol, vol.166, pp.7381-7389, 2001. ,
Role of dendritic cells in antibody-dependent enhancement of dengue virus infection, J Virol, vol.82, pp.3939-51, 2008. ,
Porcine FccRIIb mediates enhancement of porcine reproductive and respiratory syndrome virus (PRRSV) infection, PLoS ONE, vol.6, p.28721, 2011. ,
IgG opsonization of HIV impedes provirus formation in and infection of dendritic cells and subsequent long-term transfer to T cells, J Immunol, vol.178, pp.7840-7848, 2007. ,
The capacity of Salmonella to survive inside dendritic cells and prevent antigen presentation to T cells is host specific, Immunology, vol.124, pp.522-555, 2008. ,
Fc receptor signaling and trafficking: a connection for antigen processing, Immunol Rev, vol.172, pp.279-84, 1999. ,
IgG Fc receptors, Annu Rev Immunol, vol.19, pp.275-90, 2001. ,
Fc receptors, Curr Opin Immunol, vol.9, pp.121-126, 1997. ,
URL : https://hal.archives-ouvertes.fr/hal-01996170
Activating and inhibitory Fcc receptors can differentially modulate T cell-mediated autoimmunity, Eur J Immunol, vol.38, pp.2241-50, 2008. ,
Immunobiology of dendritic cells, Annu Rev Immunol, vol.18, pp.767-811, 2000. ,
Antigen presentation to naive CD4 T cells in the lymph node ,
, Nat Immunol, vol.4, pp.733-742, 2003.
Characterization of two antigenic sites recognized by neutralizing monoclonal antibodies directed against the fusion glycoprotein of human respiratory syncytial virus, J Gen Virol, vol.73, pp.2225-2259, 1992. ,
Prophylactic administration of a complementarity-determining region derived from a neutralizing monoclonal antibody is effective against respiratory syncytial virus infection in BALB/c mice, J Virol, vol.72, pp.807-817, 1998. ,
Use of synthetic peptides to locate neutralizing antigenic domains on the fusion protein of respiratory syncytial virus, J Gen Virol, vol.72, pp.1051-1059, 1991. ,
DO11.10 and OT-II T cells recognize a C-terminal ovalbumin 323-339 epitope, J Immunol, vol.164, pp.4706-4718, 2000. ,
Respiratory syncytial virus detection in cells and clinical samples by using three new monoclonal antibodies, J Med Virol, pp.86-1256, 2014. ,
Surface expression of the hRSV nucleoprotein impairs immunological synapse formation with T cells, Proc Natl Acad Sci U S A, vol.111, pp.3214-3237, 2014. ,
Infection and maturation of monocyte-derived human dendritic cells by human respiratory syncytial virus, human metapneumovirus, and human parainfluenza virus type 3, Virology, vol.385, pp.169-82, 2009. ,
Respiratory syncytial virus infects and abortively replicates in the lungs in spite of preexisting immunity, J Virol, vol.81, pp.9443-50, 2007. ,
Cross-linking of CD32 induces maturation of human monocyte-derived dendritic cells via NF-jB signaling pathway, J Immunol, vol.170, pp.3963-70, 2003. ,
A critical role for Syk protein tyrosine kinase in Fc receptor-mediated antigen presentation and induction of dendritic cell maturation, J Immunol, vol.170, pp.846-52, 2003. ,
Fc receptor-mediated antiviral antibodies, Curr Opin HIV AIDS, vol.4, pp.388-93, 2009. ,
Sustained increases in numbers of pulmonary dendritic cells after respiratory syncytial virus infection, J Allergy Clin Immunol, vol.113, pp.127-160, 2004. ,
Subversion of pulmonary dendritic cell function by paramyxovirus infections, J Immunol, vol.182, pp.3072-83, 2009. ,
Impaired IgG-dependent anaphylaxis and Arthus reaction in Fcc RIII (CD16) deficient mice, Immunity, vol.5, pp.181-189, 1996. ,
Ligation of Fcc receptor IIB inhibits antibody-dependent enhancement of dengue virus infection, Proc Natl Acad Sci U S A, vol.108, pp.12479-84, 2011. ,
Fcc receptor-mediated induction of dendritic cell maturation and major histocompatibility complex class I-restricted antigen presentation after immune complex internalization, J Exp Med, vol.189, pp.371-80, 1999. ,
Structure of a major antigenic site on the respiratory syncytial virus fusion glycoprotein in complex with neutralizing antibody 101F, J Virol, vol.84, pp.12236-12280, 2010. ,
Binding of neutralizing monoclonal antibodies to regions of the fusion protein of ª, J Gen Virol, vol.147, pp.2559-65, 1993. ,
Biological activity, binding site and affinity of monoclonal antibodies to the fusion protein of respiratory syncytial virus, J Gen Virol, vol.75, pp.2813-2822, 1994. ,
Neutralization epitopes of the F glycoprotein of respiratory syncytial virus: effect of mutation upon fusion function, J Virol, vol.63, pp.2941-50, 1989. ,
Antibodies for prevention and treatment of respiratory syncytial virus infections in children, Antivir Ther, vol.17, pp.201-212, 2012. ,
Abortive replication of influenza virus in mouse dendritic cells, J Virol, vol.86, pp.5922-5927, 2012. ,
A mouse model for immunization with ex vivo virus-infected dendritic cells, Cell Immunol, vol.206, pp.107-122, 2000. ,
Herpes simplex virus products in productive and abortive infection. II. Electron microscopic and immunological evidence for failure of virus envelopment as a cause of abortive infection, J Virol, vol.2, pp.384-92, 1968. ,
Differential enhancement of dengue virus immune complex infectivity mediated by signaling-competent and signaling-incompetent human Fcc RIA (CD64) or FccRIIA (CD32), J Virol, vol.80, pp.10128-10166, 2006. ,
Respiratory syncytial virus-induced activation and migration of respiratory dendritic cells and subsequent antigen presentation in the lung-draining lymph node, J Virol, vol.83, pp.7235-7278, 2009. ,
Central role of dendritic cells in shaping the adaptive immune response during respiratory syncytial virus infection, Future Virol, vol.6, pp.963-73, 2011. ,
Respiratory dendritic cell subsets differ in their capacity to support the induction of virus-specific cytotoxic CD8 ,
, PLoS ONE, vol.4, p.4204, 2009.
Specific migratory dendritic cells rapidly transport antigen from the airways to the thoracic lymph nodes, J Exp Med, vol.193, pp.51-60, 2001. ,
Signaling through Fcc RIII is required for optimal T helper type (Th)2 responses and Th2-mediated airway inflammation, J Exp Med, vol.204, pp.1875-89, 2007. ,
Roles of FccRIIB in nasal eosinophilia and IgE production in murine allergic rhinitis, Am J Respir Crit Care Med, vol.169, pp.105-117, 2004. ,
The secreted form of respiratory syncytial virus G glycoprotein helps the virus evade antibody-mediated restriction of replication by acting as an antigen decoy and through effects on Fc receptor-bearing leukocytes, J Virol, vol.82, pp.12191-204, 2008. ,
Absence of FccRIII results in increased proinflammatory response in FccRIII-KO cardiac recipients, Transplantation, vol.96, pp.601-609, 2013. ,
Neonatal antibody responses are attenuated by interferon-c produced by NK and T cells during RSV infection, Proc Natl Acad Sci, vol.110, pp.5576-81, 2013. ,
Infection of mice with respiratory syncytial virus during neonatal life primes for enhanced antibody and T cell responses on secondary challenge, Clin Exp Immunol, vol.153, pp.277-88, 2008. ,
The role of T cells in the enhancement of respiratory syncytial virus infection severity during adult reinfection of neonatally sensitized mice, J Virol, vol.82, pp.4115-4139, 2008. ,
Immune complex and Fc receptor-mediated augmentation of antigen presentation for in vivo Th cell responses, J Immunol, vol.164, pp.6113-6122, 2000. ,
Respiratory syncytial virus infection-risk factors for hospital admission: a case-control study, Acta Paediatr, vol.92, pp.1314-1335, 2003. ,
The role of neutralizing antibodies in protection of American Indian infants against respiratory syncytial virus disease, Pediatr Infect Dis J, vol.27, pp.207-219, 2008. ,
II. infection and disease with respect to age, immunologic status, race and sex, Am J Epidemiol, vol.98, pp.289-300, 1973. ,
Risk factors for severe respiratory syncytial virus infection among Alaska native children, Pediatrics, vol.109, pp.210-216, 2002. ,
Respiratory syncytial virus neutralizing antibodies in cord blood, respiratory syncytial virus hospitalization, and recurrent wheeze, J Allergy Clin Immunol, vol.123, pp.398-403, 2009. ,